| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
120,262 |
102,878 |
$35.78M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
76,084 |
63,571 |
$33.51M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
116,651 |
102,584 |
$25.02M |
| J9271 |
Injection, pembrolizumab, 1 mg |
2,181 |
1,456 |
$10.45M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
118,957 |
92,791 |
$9.60M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
60,302 |
51,113 |
$9.23M |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
131,442 |
37,532 |
$7.09M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
20,689 |
18,668 |
$3.80M |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
17,414 |
8,464 |
$3.10M |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
4,860 |
4,417 |
$3.02M |
| 96361 |
Intravenous infusion, hydration; each additional hour |
53,691 |
42,300 |
$2.85M |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
21,781 |
15,303 |
$2.73M |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
5,174 |
3,001 |
$2.69M |
| 70450 |
Computed tomography, head or brain; without contrast material |
22,694 |
20,032 |
$2.66M |
| 71046 |
Radiologic examination, chest; 2 views |
42,953 |
38,878 |
$2.43M |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
14,261 |
5,802 |
$2.37M |
| 59025 |
Fetal non-stress test |
13,690 |
5,833 |
$2.22M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
48,440 |
37,074 |
$2.17M |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14,835 |
12,144 |
$1.98M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
15,356 |
14,207 |
$1.96M |
| 95810 |
Polysomnography; sleep staging with 4 or more additional parameters |
2,671 |
2,489 |
$1.95M |
| J0897 |
Injection, denosumab, 1 mg |
2,282 |
1,884 |
$1.62M |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
11,837 |
10,741 |
$1.60M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
5,413 |
5,058 |
$1.51M |
| 11043 |
|
5,655 |
2,285 |
$1.46M |
| J2357 |
Injection, omalizumab, 5 mg |
2,424 |
963 |
$1.46M |
| J9299 |
Injection, nivolumab, 1 mg |
401 |
215 |
$1.46M |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
13,149 |
12,655 |
$1.40M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
13,435 |
11,927 |
$1.32M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
10,047 |
9,182 |
$1.12M |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
5,107 |
4,754 |
$1.09M |
| 93975 |
|
4,773 |
4,366 |
$976K |
| 97035 |
|
15,856 |
5,510 |
$967K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
1,405 |
1,303 |
$956K |
| 97010 |
|
33,234 |
11,641 |
$940K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
2,835 |
2,620 |
$927K |
| S9480 |
Intensive outpatient psychiatric services, per diem |
9,148 |
1,575 |
$906K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
14,187 |
12,709 |
$898K |
| 95811 |
|
1,255 |
1,179 |
$858K |
| 71045 |
Radiologic examination, chest; single view |
16,096 |
13,916 |
$760K |
| 97161 |
|
12,718 |
11,740 |
$751K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
5,839 |
5,242 |
$731K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
4,037 |
3,749 |
$716K |
| 90834 |
Psychotherapy, 45 minutes with patient |
15,708 |
9,979 |
$706K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
1,005 |
920 |
$701K |
| 93798 |
|
10,968 |
1,556 |
$654K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
7,155 |
6,641 |
$642K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,987 |
8,737 |
$623K |
| 47562 |
|
137 |
130 |
$620K |
| 76830 |
Ultrasound, transvaginal |
6,072 |
5,625 |
$612K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
5,936 |
5,568 |
$603K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,549 |
1,432 |
$590K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
6,528 |
6,060 |
$587K |
| 76641 |
|
6,280 |
5,902 |
$552K |
| 45385 |
Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) |
1,019 |
940 |
$525K |
| J2505 |
Injection, pegfilgrastim, 6 mg |
342 |
187 |
$514K |
| 90935 |
Hemodialysis procedure with single evaluation by a physician |
1,759 |
128 |
$505K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
95,906 |
28,101 |
$500K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
777 |
742 |
$493K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
31,474 |
11,945 |
$480K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
6,780 |
5,881 |
$469K |
| 94060 |
|
2,280 |
2,148 |
$444K |
| 72141 |
|
1,898 |
1,776 |
$412K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
20,394 |
13,448 |
$408K |
| 76770 |
|
4,955 |
4,609 |
$398K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
2,570 |
2,337 |
$388K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
3,245 |
2,949 |
$386K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
47,353 |
16,009 |
$378K |
| 97162 |
|
9,256 |
8,361 |
$376K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
4,070 |
3,757 |
$364K |
| 19083 |
|
318 |
295 |
$350K |
| 90791 |
Psychiatric diagnostic evaluation |
3,618 |
3,289 |
$349K |
| 77065 |
Tomosynthesis, mammo |
3,297 |
2,914 |
$346K |
| C8929 |
Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography |
1,060 |
983 |
$338K |
| 77066 |
Tomosynthesis, mammo |
2,802 |
2,587 |
$330K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
1,596 |
1,486 |
$326K |
| J0185 |
Injection, aprepitant, 1 mg |
2,736 |
1,491 |
$318K |
| 93971 |
|
4,708 |
4,300 |
$312K |
| 90832 |
Psychotherapy, 30 minutes with patient |
10,135 |
7,090 |
$304K |
| 10061 |
|
861 |
768 |
$265K |
| 71250 |
|
5,348 |
4,926 |
$260K |
| G0390 |
Trauma response team associated with hospital critical care service |
437 |
374 |
$259K |
| 76536 |
|
3,578 |
3,373 |
$258K |
| 72110 |
|
6,003 |
5,589 |
$255K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,259 |
2,988 |
$247K |
| 62323 |
|
476 |
457 |
$243K |
| 97597 |
|
5,893 |
2,735 |
$234K |
| 96415 |
|
4,474 |
2,784 |
$234K |
| 76642 |
|
4,022 |
3,739 |
$233K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
11,190 |
10,021 |
$230K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
1,871 |
322 |
$225K |
| Q5114 |
Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg |
166 |
89 |
$211K |
| 96367 |
|
5,460 |
3,239 |
$211K |
| 96417 |
|
4,887 |
2,615 |
$210K |
| 76813 |
|
2,300 |
2,109 |
$209K |
| 93970 |
|
1,594 |
1,471 |
$208K |
| 10060 |
|
1,334 |
1,224 |
$207K |
| 73221 |
|
1,115 |
1,018 |
$203K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
6,503 |
4,295 |
$202K |
| 77334 |
|
601 |
339 |
$200K |
| 73564 |
|
8,089 |
7,450 |
$184K |
| 36430 |
|
1,040 |
681 |
$175K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12,104 |
11,656 |
$172K |
| 97165 |
|
2,508 |
2,303 |
$169K |
| 86900 |
|
14,908 |
12,743 |
$166K |
| 97014 |
|
3,347 |
1,360 |
$165K |
| 58661 |
|
29 |
28 |
$159K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
4,636 |
4,214 |
$158K |
| G0498 |
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion |
898 |
465 |
$158K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
28 |
27 |
$150K |
| 70491 |
|
910 |
831 |
$142K |
| 72050 |
|
2,385 |
2,169 |
$141K |
| 99215 |
Prolong outpt/office vis |
993 |
870 |
$136K |
| 77336 |
|
2,297 |
697 |
$136K |
| 77080 |
|
1,552 |
1,454 |
$135K |
| 76801 |
|
1,320 |
1,198 |
$134K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
76,240 |
63,945 |
$134K |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
5,055 |
3,032 |
$133K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
8,828 |
7,840 |
$131K |
| 70496 |
|
745 |
674 |
$107K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,786 |
2,565 |
$105K |
| J0881 |
Injection, darbepoetin alfa, 1 microgram (non-esrd use) |
1,223 |
701 |
$102K |
| 71271 |
|
1,023 |
981 |
$100K |
| 93017 |
|
2,344 |
2,172 |
$92K |
| 97166 |
|
1,822 |
1,642 |
$91K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
10,809 |
5,507 |
$90K |
| 76825 |
|
189 |
177 |
$89K |
| 73030 |
|
6,839 |
6,150 |
$87K |
| 96411 |
|
1,472 |
844 |
$78K |
| Q5111 |
Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg |
59 |
38 |
$78K |
| 97535 |
Self-care/home management training, each 15 minutes |
3,593 |
2,486 |
$77K |
| 0001A |
|
2,316 |
2,213 |
$76K |
| 72100 |
|
1,783 |
1,606 |
$75K |
| 73630 |
|
7,136 |
6,559 |
$74K |
| G0121 |
Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk |
110 |
103 |
$74K |
| 0002A |
|
2,142 |
2,067 |
$73K |
| 72131 |
|
1,671 |
1,494 |
$72K |
| 77300 |
|
404 |
264 |
$69K |
| Q0138 |
Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) |
355 |
235 |
$68K |
| 74183 |
|
222 |
217 |
$66K |
| J9306 |
Injection, pertuzumab, 1 mg |
18 |
12 |
$65K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,935 |
1,622 |
$65K |
| 73130 |
|
6,416 |
5,836 |
$60K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
539 |
413 |
$58K |
| 74018 |
|
3,411 |
2,940 |
$58K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,632 |
1,517 |
$58K |
| 72070 |
|
1,566 |
1,421 |
$57K |
| 98967 |
|
3,043 |
967 |
$56K |
| J0882 |
Injection, darbepoetin alfa, 1 microgram (for esrd on dialysis) |
393 |
98 |
$56K |
| 73610 |
|
7,284 |
6,486 |
$54K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
5,485 |
4,963 |
$53K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
5,464 |
4,944 |
$53K |
| 73110 |
|
4,813 |
4,263 |
$51K |
| 76882 |
|
802 |
739 |
$50K |
| 70486 |
|
2,598 |
2,364 |
$50K |
| 73700 |
|
1,082 |
973 |
$48K |
| 74174 |
|
288 |
259 |
$48K |
| 77386 |
|
295 |
12 |
$47K |
| 73502 |
|
4,029 |
3,653 |
$47K |
| 77412 |
|
410 |
40 |
$46K |
| Q5106 |
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units |
1,000 |
280 |
$44K |
| 95806 |
|
451 |
407 |
$44K |
| J2506 |
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg |
85 |
52 |
$43K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
411 |
377 |
$42K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
78 |
64 |
$41K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
591 |
531 |
$40K |
| 97116 |
|
2,859 |
1,843 |
$40K |
| 90674 |
|
2,022 |
1,834 |
$38K |
| 72158 |
|
122 |
112 |
$38K |
| 52356 |
|
18 |
13 |
$36K |
| 78431 |
|
58 |
57 |
$34K |
| 76870 |
|
1,287 |
1,169 |
$34K |
| M0245 |
Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring |
108 |
97 |
$34K |
| L4350 |
Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf |
1,316 |
1,219 |
$29K |
| 72040 |
|
906 |
791 |
$27K |
| L4360 |
Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
301 |
284 |
$25K |
| 74178 |
|
144 |
130 |
$24K |
| 36591 |
|
2,127 |
1,559 |
$24K |
| 93270 |
|
1,575 |
1,444 |
$24K |
| 72197 |
|
67 |
66 |
$24K |
| 94660 |
|
704 |
508 |
$23K |
| 98968 |
|
1,027 |
317 |
$23K |
| 73562 |
|
1,426 |
1,307 |
$23K |
| M0243 |
Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring |
64 |
58 |
$23K |
| 74019 |
|
1,007 |
927 |
$22K |
| 93225 |
|
432 |
398 |
$22K |
| 64721 |
|
26 |
24 |
$22K |
| 80053 |
Comprehensive metabolic panel |
151,399 |
118,142 |
$21K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
184,933 |
137,256 |
$20K |
| 73080 |
|
2,322 |
2,133 |
$19K |
| 73140 |
|
2,717 |
2,371 |
$19K |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
558 |
505 |
$18K |
| 78451 |
|
29 |
28 |
$18K |
| 97164 |
|
1,005 |
895 |
$18K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
19,495 |
17,430 |
$18K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
18 |
12 |
$17K |
| M0247 |
Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
52 |
49 |
$17K |
| 88342 |
|
3,632 |
3,166 |
$17K |
| 36561 |
|
16 |
15 |
$17K |
| J9155 |
Injection, degarelix, 1 mg |
150 |
129 |
$17K |
| 72114 |
|
209 |
201 |
$17K |
| 96402 |
|
1,662 |
1,321 |
$17K |
| L3809 |
Wrist hand finger orthosis, without joint(s), prefabricated, off-the-shelf, any type |
237 |
219 |
$17K |
| 93880 |
|
189 |
167 |
$16K |
| 92610 |
|
203 |
167 |
$16K |
| 90675 |
|
76 |
28 |
$15K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
11,163 |
6,901 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
11,264 |
10,038 |
$14K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
208 |
197 |
$14K |
| J9217 |
Leuprolide acetate (for depot suspension), 7.5 mg |
90 |
77 |
$14K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
39 |
32 |
$13K |
| M0222 |
Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
56 |
55 |
$13K |
| 10005 |
|
30 |
28 |
$12K |
| 64483 |
|
13 |
13 |
$12K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,567 |
1,389 |
$11K |
| 90732 |
|
152 |
133 |
$11K |
| 96409 |
|
112 |
67 |
$10K |
| 73590 |
|
1,930 |
1,764 |
$10K |
| L3807 |
Wrist hand finger orthosis, without joint(s), prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
832 |
774 |
$10K |
| 77290 |
|
70 |
52 |
$10K |
| 76970 |
|
131 |
121 |
$10K |
| 93923 |
|
156 |
140 |
$9K |
| 20553 |
|
42 |
38 |
$9K |
| 20550 |
|
46 |
38 |
$8K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
45 |
38 |
$8K |
| G0101 |
Cervical or vaginal cancer screening; pelvic and clinical breast examination |
218 |
102 |
$8K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
4,071 |
3,823 |
$7K |
| J9070 |
Cyclophosphamide, 100 mg |
57 |
28 |
$7K |
| 72156 |
|
44 |
41 |
$7K |
| 80061 |
Lipid panel |
1,093 |
945 |
$7K |
| H0035 |
Mental health partial hospitalization, treatment, less than 24 hours |
54 |
12 |
$7K |
| 95910 |
|
30 |
29 |
$7K |
| 73090 |
|
1,390 |
1,259 |
$6K |
| C9463 |
Injection, aprepitant, 1 mg |
110 |
44 |
$6K |
| 93308 |
|
44 |
40 |
$6K |
| 83880 |
|
10,218 |
8,391 |
$6K |
| 71100 |
|
1,592 |
1,463 |
$5K |
| 90686 |
|
318 |
301 |
$5K |
| 94726 |
|
1,695 |
1,611 |
$5K |
| 72170 |
|
847 |
768 |
$5K |
| 73560 |
|
351 |
328 |
$5K |
| 78306 |
|
31 |
26 |
$5K |
| 81025 |
|
45,755 |
39,880 |
$5K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
50 |
28 |
$4K |
| 82728 |
|
4,323 |
3,976 |
$4K |
| 74240 |
|
27 |
26 |
$4K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
14,452 |
11,200 |
$4K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
5,990 |
5,464 |
$4K |
| 0064A |
|
96 |
96 |
$3K |
| 73552 |
|
635 |
582 |
$3K |
| 70498 |
|
754 |
687 |
$3K |
| 86923 |
|
457 |
333 |
$3K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
11,345 |
10,061 |
$3K |
| 83735 |
|
123,473 |
96,790 |
$3K |
| 0004A |
|
83 |
79 |
$3K |
| 73060 |
|
633 |
541 |
$3K |
| 73120 |
|
58 |
53 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
66,814 |
48,710 |
$3K |
| 81002 |
|
8,669 |
5,940 |
$3K |
| 82962 |
|
50,390 |
23,208 |
$3K |
| 95909 |
|
13 |
13 |
$3K |
| 83550 |
|
4,182 |
3,878 |
$3K |
| 97163 |
|
59 |
52 |
$3K |
| 0031A |
|
70 |
67 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
24,691 |
18,489 |
$2K |
| 0124A |
|
85 |
75 |
$2K |
| 90677 |
|
16 |
16 |
$2K |
| 72192 |
|
56 |
52 |
$2K |
| 85610 |
|
14,484 |
11,963 |
$2K |
| 86780 |
|
219 |
180 |
$2K |
| 97602 |
|
312 |
187 |
$2K |
| 76857 |
|
25 |
25 |
$2K |
| 83540 |
|
4,215 |
3,899 |
$2K |
| 72128 |
|
24 |
24 |
$2K |
| 84443 |
Thyroid stimulating hormone (TSH) |
6,325 |
5,480 |
$2K |
| 71101 |
|
374 |
335 |
$2K |
| 73660 |
|
305 |
281 |
$2K |
| 97760 |
|
92 |
66 |
$2K |
| 74420 |
|
75 |
67 |
$2K |
| J1750 |
Injection, iron dextran, 50 mg |
26 |
14 |
$2K |
| J2359 |
Injection, olanzapine, 0.5 mg |
277 |
232 |
$2K |
| 95816 |
|
14 |
13 |
$2K |
| 12001 |
|
2,421 |
2,266 |
$2K |
| G0399 |
Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation |
14 |
14 |
$2K |
| 29515 |
|
12 |
12 |
$1K |
| 74230 |
|
27 |
25 |
$1K |
| 88307 |
|
1,619 |
1,382 |
$1K |
| 0054A |
|
44 |
43 |
$1K |
| 90694 |
|
57 |
57 |
$1K |
| 84702 |
|
6,715 |
5,548 |
$1K |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
406 |
155 |
$1K |
| 82330 |
|
1,690 |
956 |
$1K |
| 12002 |
|
1,106 |
1,013 |
$1K |
| 0011A |
|
68 |
57 |
$1K |
| 96523 |
|
177 |
110 |
$1K |
| 83615 |
|
4,284 |
3,294 |
$1K |
| 82607 |
|
1,538 |
1,425 |
$1K |
| J2997 |
Injection, alteplase recombinant, 1 mg |
14 |
12 |
$1K |
| 72146 |
|
15 |
12 |
$970.05 |
| 0012A |
|
55 |
45 |
$969.00 |
| 83690 |
|
57,842 |
49,484 |
$955.84 |
| 87640 |
|
650 |
605 |
$949.59 |
| 87641 |
|
445 |
409 |
$910.77 |
| 70490 |
|
13 |
12 |
$890.16 |
| 88360 |
|
620 |
542 |
$878.31 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
17,231 |
15,179 |
$850.76 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
5,138 |
4,910 |
$838.49 |
| 86850 |
|
13,394 |
11,592 |
$799.55 |
| 73100 |
|
65 |
52 |
$777.85 |
| 12011 |
|
1,346 |
1,273 |
$748.69 |
| 82784 |
|
749 |
648 |
$683.98 |
| 85730 |
|
4,484 |
4,037 |
$665.40 |
| J0885 |
Injection, epoetin alfa, (for non-esrd use), 1000 units |
56 |
13 |
$652.12 |
| 0072A |
|
16 |
16 |
$600.00 |
| 0071A |
|
16 |
16 |
$600.00 |
| 84484 |
|
55,177 |
38,132 |
$590.51 |
| 86901 |
|
14,952 |
12,744 |
$522.50 |
| 85379 |
|
7,640 |
6,972 |
$509.53 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
4,736 |
4,087 |
$509.18 |
| 88304 |
|
2,233 |
2,028 |
$505.72 |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
1,438 |
1,266 |
$481.95 |
| 93242 |
|
15 |
14 |
$466.29 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
13,696 |
11,602 |
$442.66 |
| 87077 |
|
7,978 |
7,137 |
$441.61 |
| 87507 |
|
45 |
41 |
$398.02 |
| 81003 |
|
41,252 |
35,972 |
$387.49 |
| 83605 |
|
18,514 |
14,357 |
$383.30 |
| 82803 |
|
3,074 |
2,440 |
$382.93 |
| 82746 |
|
556 |
502 |
$363.97 |
| 82378 |
|
621 |
523 |
$347.53 |
| 80076 |
|
2,636 |
2,210 |
$342.94 |
| 82947 |
|
419 |
185 |
$336.22 |
| 90715 |
|
4,822 |
4,197 |
$307.53 |
| J0134 |
Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg |
154 |
132 |
$300.44 |
| 85045 |
|
1,335 |
1,158 |
$271.22 |
| 84165 |
|
641 |
555 |
$264.28 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
2,245 |
2,139 |
$259.95 |
| 85027 |
|
3,934 |
2,816 |
$259.53 |
| 86140 |
|
2,018 |
1,786 |
$237.12 |
| 96401 |
|
81 |
27 |
$236.28 |
| 84703 |
|
6,047 |
5,528 |
$232.54 |
| 36600 |
|
677 |
607 |
$229.85 |
| C2617 |
Stent, non-coronary, temporary, without delivery system |
350 |
311 |
$229.46 |
| 29125 |
|
1,004 |
903 |
$223.32 |
| 87186 |
|
6,404 |
5,741 |
$218.24 |
| 84439 |
|
1,421 |
1,266 |
$205.99 |
| C1769 |
Guide wire |
3,013 |
2,481 |
$178.00 |
| 81001 |
|
16,677 |
14,427 |
$175.10 |
| 87040 |
|
12,418 |
6,014 |
$173.24 |
| 83521 |
|
535 |
466 |
$173.04 |
| 97799 |
|
58 |
13 |
$160.00 |
| 82565 |
|
2,156 |
1,355 |
$154.23 |
| 85652 |
|
3,244 |
2,850 |
$150.84 |
| 80143 |
|
1,095 |
1,002 |
$147.86 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
33,746 |
29,898 |
$147.61 |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
103 |
92 |
$142.35 |
| G0378 |
Hospital observation service, per hour |
13,136 |
7,538 |
$129.71 |
| 93246 |
|
19 |
17 |
$127.17 |
| 87070 |
|
3,297 |
2,675 |
$126.06 |
| 51702 |
|
27 |
24 |
$118.19 |
| 82010 |
|
2,915 |
2,492 |
$118.13 |
| 84100 |
|
4,801 |
2,903 |
$108.57 |
| 82570 |
|
720 |
588 |
$107.16 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
76,318 |
53,648 |
$102.90 |
| 76820 |
|
209 |
101 |
$101.00 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
34 |
19 |
$92.94 |
| J0136 |
Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg |
28 |
27 |
$90.00 |
| 73000 |
|
17 |
14 |
$87.79 |
| 87088 |
|
2,326 |
2,109 |
$85.76 |
| L3808 |
Wrist hand finger orthosis, rigid without joints, may include soft interface material; straps, custom fabricated, includes fitting and adjustment |
590 |
551 |
$83.01 |
| 82247 |
|
19 |
13 |
$81.43 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
1,147 |
1,046 |
$81.26 |
| 82077 |
|
2,907 |
2,565 |
$80.03 |
| 73070 |
|
12 |
12 |
$78.38 |
| 84132 |
|
3,121 |
2,096 |
$74.63 |
| 87205 |
|
3,639 |
2,887 |
$72.32 |
| 84156 |
|
546 |
437 |
$70.10 |
| 84134 |
|
137 |
107 |
$69.60 |
| 82550 |
|
8,669 |
7,281 |
$62.62 |
| 82533 |
|
145 |
104 |
$62.28 |
| 87081 |
|
1,160 |
1,081 |
$57.06 |
| 87184 |
|
555 |
496 |
$55.86 |
| 87400 |
|
1,418 |
1,321 |
$55.64 |
| 84550 |
|
1,113 |
883 |
$54.63 |
| 84152 |
|
214 |
187 |
$52.68 |
| 85018 |
|
2,081 |
1,423 |
$51.98 |
| 84155 |
|
179 |
157 |
$51.29 |
| 86592 |
|
12 |
12 |
$48.84 |
| 82375 |
|
742 |
670 |
$47.08 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
33,169 |
26,626 |
$43.50 |
| 82553 |
|
2,694 |
2,342 |
$42.66 |
| 87807 |
|
195 |
186 |
$41.32 |
| 82150 |
|
1,418 |
1,254 |
$39.66 |
| 83883 |
|
101 |
90 |
$38.94 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,565 |
2,401 |
$36.83 |
| 96376 |
|
11,743 |
8,432 |
$34.01 |
| J1836 |
Injection, metronidazole, 10 mg |
708 |
436 |
$27.27 |
| 86803 |
|
29 |
25 |
$27.26 |
| 90714 |
|
1,533 |
1,441 |
$27.19 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
7,953 |
6,439 |
$27.16 |
| 94644 |
|
1,047 |
930 |
$26.99 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15,494 |
10,219 |
$25.28 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
1,738 |
1,428 |
$24.98 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
217 |
190 |
$24.89 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
34,488 |
29,551 |
$22.50 |
| 99406 |
|
13 |
12 |
$22.34 |
| 83050 |
|
640 |
587 |
$21.12 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
44,878 |
35,690 |
$18.22 |
| 87075 |
|
824 |
626 |
$18.08 |
| J2704 |
Injection, propofol, 10 mg |
25,517 |
18,147 |
$17.46 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
26,929 |
21,239 |
$17.07 |
| 80179 |
|
1,066 |
979 |
$16.44 |
| J1790 |
Injection, droperidol, up to 5 mg |
2,638 |
2,225 |
$15.16 |
| 82374 |
|
678 |
343 |
$14.01 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
2,844 |
2,495 |
$13.65 |
| 85014 |
|
711 |
301 |
$13.56 |
| 80164 |
|
206 |
178 |
$12.94 |
| 82435 |
|
658 |
332 |
$11.88 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
2,223 |
1,939 |
$11.56 |
| J7510 |
Prednisolone oral, per 5 mg |
160 |
155 |
$11.03 |
| G0008 |
Administration of influenza virus vaccine |
1,850 |
1,693 |
$10.04 |
| 82310 |
|
304 |
150 |
$9.86 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
699 |
549 |
$9.03 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
18,870 |
14,896 |
$7.16 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
10,054 |
5,264 |
$5.58 |
| 84075 |
|
258 |
203 |
$4.85 |
| 82040 |
|
203 |
155 |
$4.35 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
844 |
696 |
$3.55 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
11,277 |
8,385 |
$3.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
7,799 |
6,389 |
$3.39 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
816 |
673 |
$3.34 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
11,150 |
9,911 |
$3.29 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
8,143 |
5,913 |
$3.03 |
| 82248 |
|
21 |
13 |
$2.85 |
| J1920 |
Injection, labetalol hydrochloride, 5 mg |
270 |
237 |
$2.44 |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
8,848 |
7,687 |
$2.41 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
20,467 |
14,679 |
$2.21 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
9,421 |
4,948 |
$2.00 |
| J3480 |
Injection, potassium chloride, per 2 meq |
3,506 |
1,603 |
$1.70 |
| J2060 |
Injection, lorazepam, 2 mg |
6,354 |
5,103 |
$1.67 |
| J1630 |
Injection, haloperidol, up to 5 mg |
3,238 |
2,797 |
$1.66 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
6,240 |
3,766 |
$1.20 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
11,667 |
8,471 |
$0.88 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
230 |
201 |
$0.62 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
216 |
188 |
$0.57 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
19,264 |
14,723 |
$0.41 |
| J1644 |
Injection, heparin sodium, per 1000 units |
6,519 |
3,032 |
$0.34 |
| G8981 |
Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals |
50 |
41 |
$0.24 |
| 84520 |
|
1,114 |
486 |
$0.18 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
39 |
29 |
$0.16 |
| G8996 |
Swallowing functional limitation, current status at therapy episode outset and at reporting intervals |
87 |
72 |
$0.09 |
| G8997 |
Swallowing functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
86 |
71 |
$0.09 |
| Q0222 |
Injection, bebtelovimab, 175 mg |
68 |
66 |
$0.03 |
| Q0163 |
Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
8,079 |
5,502 |
$0.02 |
| Q0245 |
Injection, bamlanivimab and etesevimab, 2100 mg |
130 |
117 |
$0.02 |
| 36416 |
|
443 |
281 |
$0.00 |
| J2371 |
Injection, phenylephrine hydrochloride, 20 micrograms |
976 |
837 |
$0.00 |
| J1815 |
Injection, insulin, per 5 units |
9,205 |
3,771 |
$0.00 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
682 |
595 |
$0.00 |
| A9585 |
Injection, gadobutrol, 0.1 ml |
6,496 |
5,811 |
$0.00 |
| J9045 |
Injection, carboplatin, 50 mg |
1,734 |
870 |
$0.00 |
| J1940 |
Injection, furosemide, up to 20 mg |
2,816 |
1,563 |
$0.00 |
| J7050 |
Infusion, normal saline solution, 250 cc |
24,771 |
12,380 |
$0.00 |
| J2370 |
Injection, phenylephrine hcl, up to 1 ml |
2,481 |
2,110 |
$0.00 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
428 |
320 |
$0.00 |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
184 |
153 |
$0.00 |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
3,257 |
2,506 |
$0.00 |
| 96368 |
|
2,251 |
1,357 |
$0.00 |
| 86706 |
|
76 |
54 |
$0.00 |
| J9267 |
Injection, paclitaxel, 1 mg |
1,804 |
687 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,714 |
2,483 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
78 |
64 |
$0.00 |
| 87147 |
|
641 |
578 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
134 |
127 |
$0.00 |
| 88341 |
|
1,823 |
1,563 |
$0.00 |
| A4648 |
Tissue marker, implantable, any type, each |
1,388 |
1,245 |
$0.00 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
256 |
232 |
$0.00 |
| G0009 |
Administration of pneumococcal vaccine |
247 |
223 |
$0.00 |
| J2785 |
Injection, regadenoson, 0.1 mg |
903 |
841 |
$0.00 |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
4,197 |
1,453 |
$0.00 |
| 95886 |
|
617 |
579 |
$0.00 |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
157 |
144 |
$0.00 |
| 91305 |
|
132 |
124 |
$0.00 |
| J3360 |
Injection, diazepam, up to 5 mg |
371 |
333 |
$0.00 |
| A9503 |
Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries |
147 |
134 |
$0.00 |
| 83930 |
|
126 |
113 |
$0.00 |
| 87015 |
|
106 |
84 |
$0.00 |
| 11046 |
|
704 |
252 |
$0.00 |
| 87340 |
|
264 |
204 |
$0.00 |
| J3490 |
Unclassified drugs |
433,366 |
128,361 |
$0.00 |
| A6197 |
Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing |
92 |
65 |
$0.00 |
| 89060 |
|
60 |
53 |
$0.00 |
| C1781 |
Mesh (implantable) |
198 |
189 |
$0.00 |
| 99153 |
Mod sedat endo service >5yrs |
593 |
504 |
$0.00 |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
462 |
413 |
$0.00 |
| 84480 |
|
37 |
37 |
$0.00 |
| 11045 |
|
3,217 |
1,191 |
$0.00 |
| 29130 |
|
14 |
12 |
$0.00 |
| 91307 |
|
32 |
32 |
$0.00 |
| A6214 |
Foam dressing, wound cover, sterile, pad size more than 48 sq. in., with any size adhesive border, each dressing |
363 |
225 |
$0.00 |
| A6213 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., with any size adhesive border, each dressing |
42 |
37 |
$0.00 |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
68 |
63 |
$0.00 |
| A6022 |
Collagen dressing, sterile, size more than 16 sq. in. but less than or equal to 48 sq. in., each |
110 |
73 |
$0.00 |
| 96377 |
|
131 |
75 |
$0.00 |
| 99292 |
|
28 |
26 |
$0.00 |
| 86308 |
|
230 |
212 |
$0.00 |
| 88300 |
|
34 |
27 |
$0.00 |
| 51798 |
|
29 |
25 |
$0.00 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
228 |
164 |
$0.00 |
| 91306 |
|
96 |
96 |
$0.00 |
| J7121 |
5% dextrose in lactated ringers infusion, up to 1000 cc |
440 |
296 |
$0.00 |
| A4217 |
Sterile water/saline, 500 ml |
696 |
533 |
$0.00 |
| 36410 |
|
15 |
14 |
$0.00 |
| 91303 |
|
70 |
67 |
$0.00 |
| 76377 |
|
27 |
25 |
$0.00 |
| Q5115 |
Injection, rituximab-abbs, biosimilar, (truxima), 10 mg |
36 |
12 |
$0.00 |
| J0697 |
Injection, sterile cefuroxime sodium, per 750 mg |
276 |
219 |
$0.00 |
| J3535 |
Drug administered through a metered dose inhaler |
183 |
169 |
$0.00 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
33 |
25 |
$0.00 |
| 91301 |
|
140 |
117 |
$0.00 |
| Q9963 |
High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
17 |
13 |
$0.00 |
| 77001 |
|
27 |
25 |
$0.00 |
| 86704 |
|
21 |
14 |
$0.00 |
| 90839 |
|
203 |
160 |
$0.00 |
| J0456 |
Injection, azithromycin, 500 mg |
30 |
25 |
$0.00 |
| Q0247 |
Injection, sotrovimab, 500 mg |
62 |
57 |
$0.00 |
| 87493 |
|
12 |
12 |
$0.00 |
| A9555 |
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries |
58 |
57 |
$0.00 |
| 86880 |
|
17 |
14 |
$0.00 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
613 |
562 |
$0.00 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
13 |
13 |
$0.00 |
| 99152 |
|
1,900 |
1,624 |
$0.00 |
| 94729 |
|
2,270 |
2,134 |
$0.00 |
| 83970 |
|
93 |
68 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
558 |
490 |
$0.00 |
| 76376 |
|
1,810 |
1,714 |
$0.00 |
| 76827 |
|
173 |
164 |
$0.00 |
| 93325 |
|
303 |
292 |
$0.00 |
| 94645 |
|
41 |
36 |
$0.00 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
6,051 |
3,030 |
$0.00 |
| J3370 |
Injection, vancomycin hcl, 500 mg |
2,122 |
1,463 |
$0.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
3,835 |
3,031 |
$0.00 |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
761 |
715 |
$0.00 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
928 |
839 |
$0.00 |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
1,372 |
1,159 |
$0.00 |
| J1756 |
Injection, iron sucrose, 1 mg |
2,243 |
1,036 |
$0.00 |
| J0640 |
Injection, leucovorin calcium, per 50 mg |
2,155 |
477 |
$0.00 |
| 98966 |
|
151 |
47 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
535 |
487 |
$0.00 |
| 84295 |
|
950 |
474 |
$0.00 |
| J1953 |
Injection, levetiracetam, 10 mg |
107 |
80 |
$0.00 |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
12 |
12 |
$0.00 |
| 86618 |
|
274 |
227 |
$0.00 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
682 |
616 |
$0.00 |
| Q0244 |
Injection, casirivimab and imdevimab, 1200 mg |
43 |
38 |
$0.00 |
| C1729 |
Catheter, drainage |
725 |
417 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
104 |
104 |
$0.00 |
| Q9957 |
Injection, perflutren lipid microspheres, per ml |
1,256 |
1,163 |
$0.00 |
| 93356 |
|
1,744 |
1,665 |
$0.00 |
| 84450 |
|
454 |
375 |
$0.00 |
| J9263 |
Injection, oxaliplatin, 0.5 mg |
516 |
175 |
$0.00 |
| 88173 |
|
550 |
425 |
$0.00 |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
730 |
703 |
$0.00 |
| J9190 |
Injection, fluorouracil, 500 mg |
2,001 |
588 |
$0.00 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
64 |
54 |
$0.00 |
| 88312 |
|
245 |
226 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
250 |
232 |
$0.00 |
| 86334 |
|
29 |
25 |
$0.00 |
| 97598 |
|
192 |
89 |
$0.00 |
| 88313 |
|
14 |
14 |
$0.00 |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
160 |
158 |
$0.00 |
| 77012 |
|
36 |
30 |
$0.00 |
| A6210 |
Foam dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., without adhesive border, each dressing |
23 |
14 |
$0.00 |
| 90750 |
|
36 |
27 |
$0.00 |
| J2004 |
Injection, lidocaine hcl with epinephrine, 1 mg |
96 |
94 |
$0.00 |
| 94727 |
|
136 |
124 |
$0.00 |
| J3489 |
Injection, zoledronic acid, 1 mg |
212 |
186 |
$0.00 |
| J0295 |
Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm |
338 |
211 |
$0.00 |
| 77002 |
|
84 |
66 |
$0.00 |
| C1758 |
Catheter, ureteral |
147 |
123 |
$0.00 |
| 84460 |
|
345 |
290 |
$0.00 |
| 88112 |
|
55 |
50 |
$0.00 |
| 88302 |
|
46 |
41 |
$0.00 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
515 |
424 |
$0.00 |
| 76937 |
|
57 |
53 |
$0.00 |
| J1596 |
Injection, glycopyrrolate, 0.1 mg |
150 |
137 |
$0.00 |
| 91300 |
|
4,467 |
3,835 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
477 |
333 |
$0.00 |
| J9201 |
Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg |
260 |
74 |
$0.00 |
| J9060 |
Injection, cisplatin, powder or solution, 10 mg |
27 |
12 |
$0.00 |
| 91312 |
|
66 |
57 |
$0.00 |
| Q0169 |
Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
27 |
26 |
$0.00 |
| J2916 |
Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg |
173 |
69 |
$0.00 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
15 |
12 |
$0.00 |
| 31720 |
|
17 |
12 |
$0.00 |
| 78434 |
|
14 |
14 |
$0.00 |
| C1788 |
Port, indwelling (implantable) |
15 |
14 |
$0.00 |
| 86922 |
|
16 |
12 |
$0.00 |
| 82140 |
|
13 |
12 |
$0.00 |
| 76942 |
|
29 |
26 |
$0.00 |
| Q9950 |
Injection, sulfur hexafluoride lipid microspheres, per ml |
67 |
66 |
$0.00 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
32 |
28 |
$0.00 |
| 90653 |
|
34 |
25 |
$0.00 |
| G0109 |
Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes |
20 |
14 |
$0.00 |
| J0692 |
Injection, cefepime hydrochloride, 500 mg |
15 |
12 |
$0.00 |
| 90840 |
|
24 |
19 |
$0.00 |
| J9171 |
Injection, docetaxel, 1 mg |
13 |
12 |
$0.00 |
| 76098 |
|
13 |
12 |
$0.00 |